跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CYTARABINE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CYTARABINE INJECTION
Authorized
STANDARD
CYTARABINE INJECTION
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
366a842b853d5f12
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
366a842b853d5f12
Drug Approval Canada Name
CYTARABINE INJECTION
Product Name
CYTARABINE INJECTION
Status
Marketed
Status Date
2022-04-21
Original Market Date
2022-04-21
Din
02515296
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intrathecal , Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC01 CYTARABINE
Atc Name
l 01 bc 01
Aig Number
0108854005
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
CYTARABINE
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
366a842b853d5f12
Type
Standard
Back to Health Canada Approvals